|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.76 USD | -1.26% |
|
-1.88% | +24.64% |
| 07-16 | Ingevity Receives BASt Approval For Evotherm P35 Warm-Mix Additive In Germany | CI |
| 06-25 | Ingevity Names Ryan Cotterman as Chief Accounting Officer | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 89 | +19.14% | 3 | ||||||
| 8,074.71 | +14.13% | 17 | ||||||
| 52.26 | +6.72% | 21 | ||||||
| 1,652.9 | +2.75% | 21 | ||||||
| 1,944.17 | +4.69% | 12 | ||||||
| 1,189.09 | -0.54% | 11 | ||||||
| 56.57 | -4.28% | 14 | ||||||
| 2,967.6 | +3.29% | 30 | ||||||
| 71.35 | +2.37% | 17 | ||||||
| 203.11 | +9.05% | 9 | ||||||
| 8,311.11 | +5.44% | 9 | ||||||
| 23.61 | +12.85% | 16 | ||||||
| 663.33 | +21.05% | 9 | ||||||
| 3,092.22 | +10% | 9 | ||||||
| - | - | 39 | +30.96% | 1 | ||||
| 70 | +2.32% | 11 | ||||||
| 2,704.1 | -26.11% | 10 | ||||||
| 25.01 | -4.31% | 15 | ||||||
| 184.5 | +28.87% | 4 | ||||||
| Average | 1,653.35 | +7.29% | 13 | ||||||
| Weighted average by Cap. | 3,369.67 | +8.60% | 16 |
- Stock Market
- Stocks
- NGVT Stock
- Sector Ingevity Corporation
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
